Ausgabe 10/2023
Inhalt (6 Artikel)
Acthar® Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence
Jeffrey Kaplan, Anca Askanase, David Chu, Abdul Abdellatif, Dhiman Basu, Mehdi Mirsaeidi
Effectiveness and Safety of Remdesivir in Treating Hospitalised Patients with COVID-19: A Propensity Score Analysis of Real-Life Data from a Monocentric Observational Study in Times of Health Emergency
Nicola Ughi, Davide Paolo Bernasconi, Francesca Del Gaudio, Armanda Dicuonzo, Alessandro Maloberti, Cristina Giannattasio, Paolo Tarsia, Giovanna Travi, Francesco Scaglione, Fabrizio Colombo, Michaela Bertuzzi, Antonella Adinolfi, Maria Grazia Valsecchi, Claudio Rossetti, Oscar Massimiliano Epis
Tumor Lysis Syndrome with CD20 Monoclonal Antibodies for Chronic Lymphocytic Leukemia: Signals from the FDA Adverse Event Reporting System
Shuang Xia, Jia-ting Ma, Emanuel Raschi, Rui Ma, Bi-kui Zhang, Linna Guo, Yoshihiro Noguchi, Mayur Sarangdhar, Hui Gong, Miao Yan
A Phase 1 Study of Ensitrelvir Fumaric Acid Tablets Evaluating the Safety, Pharmacokinetics and Food Effect in Healthy Adult Populations
Ryosuke Shimizu, Takuhiro Sonoyama, Takahiro Fukuhara, Aya Kuwata, Yumiko Matsuo, Ryuji Kubota
Effectiveness of Dupilumab for Chronic Prurigo in Chinese Patients: A Real-World Case Series Study
Lu Wei, Mengting Yin, Xu Yang, Jiaying Chen, Ruimiao Wu, Heng Yang, Xia Dou
Safety of Interleukin Inhibitors in Patients with Plaque Psoriasis and Neoplasm: A Retrospective Study from Two Referral Centers
Luigi Gargiulo, Luciano Ibba, Mario Valenti, Diego Orsini, Antonio Cristaudo, Pasquale Frascione, Antonio Costanzo, Alessandra Narcisi